Trial Profile
The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure -A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Levocarnitine (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 28 Jul 2012 Primary endpoint 'New-York-Heart-Association-class' has been met.
- 26 Apr 2012 New trial record